Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, Phase 2 trial
Moisture Control: Allow peptides to reach room temperature before opening containers to avoid moisture condensation, which can contaminate and degrade peptides
Therapeutic indications: Vitamin B 12 deficiency that cannot be corrected through a healthy diet
HUBERMAN: That is, it works both similarly to growth hormone and does some things in parallel that are a little bit different as well, in particular things related to regulation of blood sugar metabolism, et cetera, all things associated with kind of youthfulness, vitality, and energy